L&K Bio Signs Strategic MOU with CGBio

[Asia Economy Reporter Hyungsoo Park] L&K Biomed, a developer of spinal implants, announced on the 14th that it has signed a memorandum of understanding (MOU) for strategic business cooperation with CGBio, a regenerative medicine specialist based on bio-material technology.

CGBio manufactures bone marrow separation kits through an original design manufacturer (ODM) method, and L&K Biomed sells the bone marrow separation kits in the United States.

This is significant as a technical business agreement for strategic cooperation and mutual growth between L&K Biomed, which has a strong sales network in the U.S. based on innovative technology in the overseas spinal implant market, and CGBio, which possesses orthobiologic technology.

Founded in 2006, CGBio is a small but strong company that develops innovative medical devices by securing new technologies such as human tissue regeneration, bio-converged medical devices, and advanced medical devices through continuous research and development (R&D) investment. Through the partnership with CGBio, L&K Biomed can secure competitiveness in the regeneration fields of cartilage and bone. This creates an opportunity to expand its presence in the U.S. market.

The concentrated solution obtained from the bone marrow separation kit used in clinical practice during autologous stem cell therapy contains mesenchymal stem cells, hematopoietic stem cells, growth factors, and cytokines. Stem cells derived from bone marrow concentrated using the bone marrow separation kit acquire the ability to differentiate into cells important for forming cartilage and bone.

The bone marrow separation kit developed by CGBio has no risk of contamination during the cultivation process, unlike existing stem cell therapies. It is safe with no immune rejection, requires less time and cost, and has rapid tissue regeneration effects. The bone marrow separation kit is one of the possible alternatives in regenerative medicine. It is used as a medical device for cartilage and bone-forming cells and pain treatment in orthopedics, neurosurgery, and other fields.

This content was produced with the assistance of AI translation services.